charantin is a type of Active Compound and its properties as follows :-
Dietry_product Qty/100gram Qty/day (Min-Max) T_half (Min-Max) Peak value (Min-Max)       Qty/gm_Ref        Qty/gm_Url            Qty/day_Ref        Qty/day_Url            T_half_Ref        T_half_Url         Peak value_Ref       Peak value_Url     
Bitter melon 50 ml 150 (minute) Duke, James A and James A Duke. Handbook Of Medicinal Herbs. 1st ed. Boca Raton, FL: CRC Press, 2002. Print. https://archive.org/stream/HandbookOfMedicinalHerbsByJamesA.Duke/HandbookOfMedicinalHerbs_djvu.txt Efird, J., Choi, Y., Davies, S., Mehra, S., Anderson, E. and Katunga, L. (2014). Potential for Improved Glycemic Control with Dietary Momordica charantia in Patients with Insulin Resistance and Pre-Diabetes. International Journal of Environmental Research http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3945602/
Bitter melon i.e.karela 50 ml 210 (minute) Duke, James A and James A Duke. Handbook Of Medicinal Herbs. 1st ed. Boca Raton, FL: CRC Press, 2002. Print. https://archive.org/stream/HandbookOfMedicinalHerbsByJamesA.Duke/HandbookOfMedicinalHerbs_djvu.txt
charantin is a type of Active Compound and its properties as follows :-
Enhencer Effect Reference Url
charantin is a type of Active Compound and its properties as follows :-
Inhibitor Effect Ref Url
charantin is a type of Active Compound and its properties as follows :-
Dietry_product Type Temperatute Ref_Temp Url_Temp

Pathway of Dietry Product


​   ► Medicine for charantin as follows :-
'Not Found'

Dietry Substance Interactions


​   ► charantin interact with medicines having some effect as follows :-
'Not Found'

ContraIndication Dietry Substance


​   ► charantin Contraindicate with medicines as follows :-
'Not Found'